Role of Cyclic AMP Response Element-Binding Protein in Cyclic AMP Inhibition of NF-κB-Mediated Transcription

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5450-5456

  Parry, Graham C N ^a   Mackman, Nigel ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; NERVE PROTEIN; SYNAPTOTAGMIN; SYNAPTOTAGMIN I;

ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; MONOCYTE; PHYSIOLOGY; PROMOTER REGION;

CALCIUM-BINDING PROTEINS; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENDOTHELIUM; HUMANS; MEMBRANE GLYCOPROTEINS; MONOCYTES; NERVE TISSUE PROTEINS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); SYNAPTOTAGMIN I; SYNAPTOTAGMINS; TRANSCRIPTION, GENETIC;

EID: 0031303091     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723.
2. Beg, A. A., and A. S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064.
3. 2) of p65 NF-κB. J. Biol. Chem. 270:15576.
4. Bull, P., T. Hunter, and I. M. Verma. 1989. Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts. Mol. Cell Biol. 9:5239.
5. Dobrzanski, P., R.-P. Ryseck, and R. Bravo. 1993. Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol. Cell. Biol. 13:1572.
6. Müller, J. M., H. W. L. Ziegler-Heitbrock, and P. A. Baeuerle. 1993. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233.
7. Collins, T. 1993. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab. Invest. 68:499.
8. Montgomery, K. F., L. Osborn, C. Hession, R. Tizard, D. Goff, C. Vassallo, P. I. Tarr, K. Bomsztyk, R. Lobb, J. M. Harlan, and T. H. Pohlman. 1991. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA 83:6523.
9. van de Stople, A., E. Caldenhoven, B. G. Stade, L. Koenderman, J. A. M. Raaijmakers, J. P. Johnson, and P. T. van der Saag. 1994. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. J. Biol. Chem. 269:6185.
10. Burchett, S. K., W. M. Weaver, J. A. Westall, A. Larsen, S. Kronheim, and C. B. Wilson. 1988. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J. Immunol. 140:3473.
11. Gregory, S. A., J. H. Morrissey, and T. S. Edgington. 1989. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol. Cell. Biol. 9:2752.
12. Brand, K., B. J. Fowler, T. S. Edgington, and N. Mackman. 1991. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol. Cell. Biol. 11:4732.
13. Ziegler-Heitbrock, H. W. L., T. Sternsdorf, J. Liese, B. Belohradsky, C. Weber, A. Wedel, R. Schreck, P. Bäuerle, and M. Ströbel. 1993. Pyrrolidine-dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J. Immunol. 151:6986.
14. Mackman, N., K. Brand, and T. S. Edgington. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J. Exp. Med. 174:1517.
15. Whitley, M. Z., D. Thanos, M. Read, T. Maniatis, and T. Collins. 1994. A striking similarity in the organization of the E-selectin and beta interferon gene promoters. Mol. Cell. Biol. 14:6464.
16. Neish, A. S., M. A. Read, D. Thanos, R. Pine, T. Maniatis, and T. Collins. 1995. Endothelial interferon regulatory factor 1 cooperates with NF-κB as a transcriptional activator of vascular cell adhesion molecule 1. Mol. Cell. Biol. 15:2558.
17. Ghersa, P., R. Hooft van Huijsduijnen, J. Whelan, Y. Cambet, R. Pescini, and J. F. DeLamarter. 1994. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J. Biol. Chem. 269:29129.
18. Pober, J. S., M. R. Slowik, L. G. De Luca, and A. J. Ritchie. 1993. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J. Immunol. 150:5114.
19. Taffet, S. M., K. J. Singhel, J. F. Overholtzer, and S. A. Shurtleff. 1989. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell. Immunol. 120:291.
20. 1 inhibit monocyte procoagulant activity in vitro. Blood 78: 382.
21. Crutchley, D. J., D. E. Solomon, and L. B. Conanan. 1992. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism. Arterioscler. Thromb. 12: 664.
22. de Prost, D., V. Ollivier, and J. Hakim. 1990. Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes. Mol. Pharmacol. 38:562.
23. Ollivier, V., S. Houssaye, C. Temisien, A. Léon, H. de Verneuil, C. Elbim, N. Mackman, T. S. Edgington, and D. de Prost. 1993. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 81:973.
24. Ollivier, V., G. C. N. Parry, R. R. Cobb, D. de Prost, and N. Mackman. 1996. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271:20828.
25. Lalli, E., and P. Sassone-Corsi. 1994. Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem. 269:17359.
26. Arias, J., A. S. Alberts, P. Brindle, F. X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and micogen responsive genes relies on a common nuclear factor. Nature 370:226.
27. Chrivia, J., R. Kwok, N. Lamb, M. Hagiwara, M. Montminy, and R. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855.
28. Kwok, R. P. S., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P. Bachinger, R. G. Brennan, S. G. E. Roberts, M. R. Green, and R. H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223.
29. Bannister, A. J., T. Oehler, D. Wilhelm, P. Angel, and T. Kouzarides. 1995. Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11: 2509.
30. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403.
31. Chakravarti, D., V. J. LaMorte, M. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montminy, and R. M. Evans. 1996. Role of CBP/P300 in nuclear receptor signalling. Nature 383:99.
32. Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D'Andrea, and D. M. Livingston. 1996. Cooperation of Stat2 and p300/CDP in signalling induced by interferon-α. Nature 383:344.
33. Petrij, F., R. H. Giles, H. G. Dauwerse, J. J. Sarls, R. C. M. Hennekam, M. Masuno, N. Tommerup, G.-J. B. van Ommen, R. H. Goodman, D. J. M. Peters, and M. H. Breuning. 1995. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376:348.
34. Janknecht, R., and T. Hunter. 1996. A growing coactivator network. Nature 383: 22.
35. Oeth, P. A., G. C. N. Parry, C. Kunsch, P. Nantermet, C. A. Rosen, and N. Mackman. 1994. Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a κB-like site. Mol. Cell. Biol. 14:3772.
36. Bannister, A. J., A. Cook, and T. Kouzarides. 1991. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene 6:1243.
37. Hagemeier, C., A. J. Bannister, A. Cook, and T. Kouzarides. 1993. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 90:1580.
38. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805.
39. Schmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805.
40. Parry, G. C. N., and N. Mackman. 1995. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler. Thromb. 15: 612.
41. Neumann, J. R., C. A. Morency, and K. O. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5: 444.
42. Mosialos, G., and T. D. Gilmore. 1993. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. Oncogene 8: 721.
43. c-rel. Mol. Cell. Biol. 11:5867.
44. Han, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171:465.
45. Levi, M., H. ten Cate, K. A. Bauer, T. van der Poll, T. S. Edgington, H. R. Büller, S. J. H. van Deventer, C. E. Hack, J. Wouter ten Cate, and R. D. Rosenberg. 1994. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J. Clin. Invest. 93:114.
46. Kerr, L. D., L. J. Ransone, P. Wamsley, M. J. Schmitt, T. G. Boyer, Q. Zhou, A. J. Berk, and I. M. Verma. 1993. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB. Nature 365:412.
47. Schmitz, M. L., G. Stelzer, H. Altmann, M. Meisterernst, and P. A. Baeuerle. 1995. Interaction of the COOH-terminal transactivation domain of p65 NF-κB with TATA-binding protein, transcription factor IIB, and coactivators. J. Biol. Chem. 270:7219.
48. Xu, X., C. Prorock, H. Ishikawa, E. Maldonado, Y. Ito, and C. Gèlinas. 1993. Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. Mol. Cell. Biol. 13:6733.
49. Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523.
50. Gerritsen, M. E., A. J. Williams, A. S. Neish, S. Moore, Y. Shi, and T. Collins. 1997. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94:2927.
51. Auphan, N., J. A. Didonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286.
52. Scheinman, R. T., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283.
53. Brostjan, C., J. Anrather, V. Csizmadia, D. Stroka, M. Soares, F. H. Bach, and H. Winkler. 1996. Glucocorticoid-mediated repression of NF-κB activity in endothelial cells does not involve induction of IκBα synthesis. J. Biol. Chem. 271: 19612.
54. Scheinman, R. I., A. Gualberto, C. M. Jewell, J. A. Cidlowski, and A. S. Baldwin. 1995. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol. Cell. Biol. 15:943.
55. Zhong, H., H. Suyang, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1997. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413.
56. Ghersa, P., J. Whelan, R. Pescini, J. F. DeLamarter, and R. Hooft van Huijsduijnen. 1994. Commonly used cat reporter vectors contain a cAMP-inducible, cryptic enhancer that co-operates with NF-κB-sites. Gene 151: 331.
57. Benzakour, O., C. Kanthou, U. Dennehy, A. A. Haq, L.-P. Berg, and V. V. Kakkar. 1995. Evaluation of the use of the luciferase-reporter-gene system for gene-regulation studies involving cyclic AMP-elevating agents. Biochem. J. 309:385.
58. Neumann, M., T. Grieshammer, S. Chuvpilo, B. Kneitz, M. Lohoff, A. Schimpl, B. R. Franza, Jr., and E. Serfling. 1995. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14:1991.